Skip to content

Annual HIV tests for high-risk groups and one-off screening for all others could have a big impact on UK's HIV epidemic

Sofosbuvir + ribavirin is safe and effective for HCV recurrence after liver transplantation

Voucher incentives improve engagement with HIV care among people who inject drugs

Sustained response to treatment reduces fatigue in hepatitis C patients

Investigational protease inhibitor TMC310911 highly potent in phase 2 study

Sofosbuvir + ribavirin for 24 weeks is highly effective against HCV genotype 4

Early antiretroviral treatment reduces risk of AIDS and HIV-related illness

PCR testing reveals high prevalence of CNS infections among people living with HIV in Zambia with CNS symptoms

Methadone and buprenorphine-naloxone both associated with reduced HIV risk among people who inject drugs